Active Filter(s):
Details:
Agreement secures a 2D patented printing technology from Vitiprints that will significantly boost production capacity and reduce production costs.
Lead Product(s): Tetrahydrocannabinol
Therapeutic Area: Neurology Product Name: CAUMZ
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Tetra BioPharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 13, 2020